These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35155572)

  • 1. Modeling the MreB-CbtA Interaction to Facilitate the Prediction and Design of Candidate Antibacterial Peptides.
    Awuni E
    Front Mol Biosci; 2021; 8():814935. PubMed ID: 35155572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CbtA toxin of Escherichia coli inhibits cell division and cell elongation via direct and independent interactions with FtsZ and MreB.
    Heller DM; Tavag M; Hochschild A
    PLoS Genet; 2017 Sep; 13(9):e1007007. PubMed ID: 28931012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YeeU enhances the bundling of cytoskeletal polymers of MreB and FtsZ, antagonizing the CbtA (YeeV) toxicity in Escherichia coli.
    Masuda H; Tan Q; Awano N; Wu KP; Inouye M
    Mol Microbiol; 2012 Jun; 84(5):979-89. PubMed ID: 22515815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of Toxin⁻Antitoxin Systems in
    Shidore T; Zeng Q; Triplett LR
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30959879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the A22-Bacterial Actin MreB Interaction through Molecular Dynamics Simulations.
    Awuni Y; Jiang S; Robinson RC; Mu Y
    J Phys Chem B; 2016 Sep; 120(37):9867-74. PubMed ID: 27600765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AimB Is a Small Protein Regulator of Cell Size and MreB Assembly.
    Werner JN; Shi H; Hsin J; Huang KC; Gitai Z; Klein EA
    Biophys J; 2020 Aug; 119(3):593-604. PubMed ID: 32416080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of A22 on the Conformation of Bacterial Actin MreB.
    Awuni E; Mu Y
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Rational Design of Peptide-Based Protein-Protein Inhibitors (Pep-PPIs) Approach by Mapping the Interaction Motifs of the PP Interface and Physicochemical Filtration: A Case on p25-Cdk5-Mediated Neurodegenerative Diseases.
    Oduro-Kwateng E; Ali M; Kehinde IO; Zhang Z; Soliman MES
    J Cell Biochem; 2024 Sep; 125(9):e30633. PubMed ID: 39148280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel MreB inhibitors with antibacterial activity against Gram (-) bacteria.
    Sagong HY; Rosado-Lugo JD; Bryan EJ; Ferrer-González E; Wang Y; Cao Y; Parhi AK; Pilch DS; LaVoie EJ
    Med Chem Res; 2022 Oct; 31(10):1679-1704. PubMed ID: 37077288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Antibacterial and Antibiofilm Activity of the MreB Inhibitor A22 Hydrochloride in Combination with Conventional Antibiotics against
    Kotzialampou A; Protonotariou E; Skoura L; Sivropoulou A
    Int J Microbiol; 2021; 2021():3057754. PubMed ID: 34484344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple conserved states characterize the twist landscape of the bacterial actin homolog MreB.
    Knapp BD; Ward MD; Bowman GR; Shi H; Huang KC
    Comput Struct Biotechnol J; 2022; 20():5838-5846. PubMed ID: 36382191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of Targeting MreB for the Development of Antibiotics.
    Awuni E
    Front Chem; 2019; 7():884. PubMed ID: 31998684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bacterial actin MreB rotates, and rotation depends on cell-wall assembly.
    van Teeffelen S; Wang S; Furchtgott L; Huang KC; Wingreen NS; Shaevitz JW; Gitai Z
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15822-7. PubMed ID: 21903929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved prediction of protein-protein interactions by a modified strategy using three conventional docking software in combination.
    Choi S; Son SH; Kim MY; Na I; Uversky VN; Kim CG
    Int J Biol Macromol; 2023 Dec; 252():126526. PubMed ID: 37633550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the Molecular Interactions of A22 with Prokaryotic Actin MreB and Eukaryotic Actin: A Computational and Experimental Study.
    Kumar A; Kukal S; Marepalli A; Kumar S; Govindarajan S; Pramanik D
    J Phys Chem B; 2024 Oct; 128(43):10553-10564. PubMed ID: 39413431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilized cyclic peptides as modulators of protein-protein interactions: promising strategies and biological evaluation.
    Cheng J; Zhou J; Kong L; Wang H; Zhang Y; Wang X; Liu G; Chu Q
    RSC Med Chem; 2023 Dec; 14(12):2496-2508. PubMed ID: 38107173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
    Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS
    J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides.
    Lu MC; Yuan ZW; Jiang YL; Chen ZY; You QD; Jiang ZY
    Mol Biosyst; 2016 Apr; 12(4):1378-87. PubMed ID: 26935067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
    Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
    J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibitors targeting Fis1/Mid51 protein-protein interactions protect against hypoxia-induced damage in cardiomyocytes.
    Zerihun M; Qvit N
    Front Pharmacol; 2023; 14():1275370. PubMed ID: 38192411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.